The Fund was significantly oversubscribed, with aggregate interest surpassing €2.0 billion. The fundraise was anchored by strong support from Stoneshield’s existing global limited partners, with a 100% re-up rate, and was expanded through commitments from a select group of new global investors, including leading sovereign wealth funds, global consultants, pensions, insurance companies, endowments, family offices, and foundations across North America, Europe, the Middle East and Asia.

Over 660 million people worldwide still lack access to electricity, while approximately 2.1 billion people rely on polluting or hazardous fuels for cooking. These challenges remain a major constraint on economic and social progress. Through Accelerate7, Lightrock aims to back businesses that expand access to modern energy, improve livelihoods, and generate attractive returns, while helping mobilise additional capital into this growing market.

Across Asia, Bain Capital has built a fully integrated platform spanning Japan, India, China, Australia, and Korea, with nearly 200 investment and operating professionals investing across Technology, Industrials, Consumer, Healthcare, and Business and Financial Services.

The Funds closed 23% above target. Reflecting the strong performance of previous funds, which have already generated in excess of $1 billion in realisations to date, over 70% of existing LPs have re-upped and increased on their previous fund’s commitments, accounting for around 50% of the total capital raised in Fund III.

Both funds were materially oversubscribed as a result of continued strong support from existing investors as well as significant interest from new investors.

KSOF represents a continuation of Kinderhook’s long-standing investment strategy, targeting control-oriented investments in lower middle market companies across its core sectors: Healthcare Services, Environmental & Industrial Services, and Light Manufacturing / Automotive. The Fund focuses on platform opportunities that are scaled-down versions of Kinderhook’s flagship approach.

Globally, this closing ranks the Fund as the largest first-time fund in the value-add space

since 2023, when the Fund was launched.

BPEA IX is the largest-ever Asia Pacific-dedicated private equity fund raised to date.

The fund received commitments from a high-quality, diverse and global investor base, including pension plans, sovereign wealth funds, endowments, foundations, insurance companies and family offices. The breadth and caliber of those partners reflect continued conviction in 26North’s differentiated strategy and platform.

Fund VI represents the largest and most diversified investor base in Lightyear’s history, including commitments from over 65 global institutions, including pension funds, insurance companies, sovereign wealth funds, endowments and foundations, and family offices. Fund VI builds on the firm’s over 25-year history of partnering with growing companies at the nexus of financial services and technology, healthcare, and business services.

It makes Eka the UK’s largest early-stage impact VC investing across health, wellbeing and sustainability.

Fund IV attracted strong demand from a broad and growing global investor base, with commitments spanning blue-chip public and corporate pension plans, investment consultants, insurance companies, sovereign wealth funds, leading global asset managers, private banks, foundations and family offices. The Fund deepens Pollen Street’s relationship with longstanding partners while also welcoming a significant group of new investors.

Fund V attracted substantial interest, with over 40 new investors from more than 20 countries, including leading pensions, asset managers, insurance companies, and family offices.

Since its debut last year, 154 has invested in an accounting services consolidation platform and in a sports & live event-focused guest services platform.

With this new fund, Jeito has now tripled its assets under management to €1.6 billion, following the closing in 2021 of fund Jeito I at $630 million (€534 million) and reinforces its position as a leading fully independent European Biopharma investor.

This fundraise builds on Blackstone Credit & Insurance’s (“BXCI”) 20-year track record investing through market cycles. Blackstone’s opportunistic credit strategy has generated a 13% net IRR since inception in 2007. Blackstone manages $520 billion of total assets across corporate and real estate credit.

NAX4 is the largest private equity fund raised that focuses on investing solely in North America.

The Fund materially surpassed its €1bn target owing to strong demand from a globally diverse group of investors including sovereign wealth funds, pension funds, insurance companies and asset managers.

Fund VII was heavily oversubscribed with demand from a globally diverse range of leading institutional investors, including pension funds, sovereign wealth funds, insurance firms, asset managers, endowments, foundations, wealth managers and family offices.

It is the largest life sciences private fund ever raised and is nearly 40% larger than its predecessor vehicle.